Search
for
Sort by
Research 30 of 1000+
- Follow-up of Nutritional and Metabolic Problems After Bariatric Surgery
- Mice lacking desmocollin 1 show epidermal fragility accompanied by barrier defects and abnormal differentiation
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Two Phase 3 Trials of Baricitinib for Alopecia Areata
- Mineral Malnutrition Following Bariatric Surgery
- Epidermal Vascular Endothelial Growth Factor Production Is Required for Permeability Barrier Homeostasis, Dermal Angiogenesis, and the Development of Epidermal Hyperplasia
- Obesity resistance of the stearoyl-CoA desaturase-deficient (<i>scd1</i> <sup>-/-</sup>) mouse results from disruption of the epidermal lipid barrier and adaptive thermoregulation
- Avaliação da qualidade de vida, perda de peso e comorbidades de pacientes submetidos à cirurgia bariátrica
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
- Baricitinib: From Rheumatoid Arthritis to COVID‐19
- Barley disease susceptibility factor RACB acts in epidermal cell polarity and positioning of the nucleus
- Procyanidin B‐3, isolated from barley and identified as a hair‐growth stimulant, has the potential to counteract inhibitory regulation by TGF‐β1
- Guidelines of care for superficial mycotic infectionsof the skin: Tinea capitis and tinea barbae
- Comparison of two in vitro models for the analysis of follicular penetration and its prevention by barrier emulsions
- Arabinogalactan proteins are involved in root hair development in barley
- Bariatric Surgery and Its Effects on the Skin and Skin Diseases
- Essential Role of Polarity Protein Par3 for Epidermal Homeostasis through Regulation of Barrier Function, Keratinocyte Differentiation, and Stem Cell Maintenance
- Treatment of severe alopecia areata with baricitinib
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- [Alopecia in women with severe and morbid obesity who undergo bariatric surgery].
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Prevention of Follicular Penetration: Barrier-Enhancing Formulations against the Penetration of Pollen Allergens into Hair Follicles
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- Hair Loss After Metabolic and Bariatric Surgery: a Systematic Review and Meta-analysis
- Association of Lifelong Intake of Barley Diet with Healthy Aging: Changes in Physical and Cognitive Functions and Intestinal Microbiome in Senescence-Accelerated Mouse-Prone 8 (SAMP8)
- Treatment of moderate-to-severe alopecia areata in pre-adolescent children with baricitinib
- Baricitinib in Alopecia Areata
- In vivo penetration of bare and lipid-coated silica nanoparticles across the human stratum corneum